| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1006 | 22 | 1148 | 90 | 1096 | 196 | 1193 |
| ERLYTX | 89 | 0 | 0 | 3 | 37 | 8 | 49 |
| GI | 189 | 1 | 52 | 11 | 134 | 25 | 152 |
| GU | 437 | 6 | 313 | 27 | 329 | 64 | 390 |
| LEUK | 139 | 1 | 52 | 11 | 134 | 21 | 128 |
| LUNG | 169 | 4 | 209 | 20 | 244 | 39 | 237 |
| LYMPH | 398 | 7 | 365 | 30 | 365 | 59 | 359 |
| MELAN | 276 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 151 | 1 | 52 | 6 | 73 | 11 | 67 |
| MULT | 22 | 0 | 0 | 7 | 85 | 12 | 73 |
| OTHER | 41 | 1 | 52 | 4 | 49 | 9 | 55 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2921 | 43 | 2243 | 210 | 2558 | 446 | 2715 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 115 | 0 | 0 | 13 | 158 | 29 | 177 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 667 | 7 | 365 | 46 | 560 | 103 | 627 |
| LUNG | 312 | 3 | 157 | 30 | 365 | 64 | 390 |
| OTHER | 36 | 1 | 52 | 4 | 49 | 10 | 61 |
| PEOLC | 130 | 3 | 157 | 14 | 170 | 32 | 195 |
| PREV | 204 | 2 | 104 | 23 | 280 | 44 | 268 |
| SURV | 18 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 563 | 5 | 261 | 43 | 524 | 99 | 603 |
| Total | 2055 | 21 | 1096 | 175 | 2130 | 386 | 2351 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1006 | 22 | 1148 | 90 | 1096 | 196 | 1193 |
| CCD | 115 | 0 | 0 | 13 | 158 | 29 | 177 |
| ERLYTX | 99 | 0 | 0 | 3 | 37 | 9 | 55 |
| GI | 189 | 1 | 52 | 11 | 134 | 25 | 152 |
| GU | 437 | 6 | 313 | 27 | 329 | 64 | 390 |
| LEUK | 806 | 8 | 417 | 57 | 694 | 124 | 755 |
| LUNG | 481 | 7 | 365 | 50 | 609 | 103 | 627 |
| LYMPH | 398 | 7 | 365 | 30 | 365 | 59 | 359 |
| MELAN | 276 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 151 | 1 | 52 | 6 | 73 | 11 | 67 |
| MULT | 22 | 0 | 0 | 7 | 85 | 12 | 73 |
| OTHER | 77 | 2 | 104 | 8 | 97 | 19 | 116 |
| PEOLC | 130 | 3 | 157 | 14 | 170 | 32 | 195 |
| PREV | 206 | 2 | 104 | 23 | 280 | 44 | 268 |
| SURV | 18 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 565 | 5 | 261 | 43 | 524 | 99 | 603 |
| Total | 4976 | 64 | 3338 | 385 | 4687 | 832 | 5066 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 623 | 14 | 730 | 57 | 694 | 124 | 755 |
| ERLYTX | 48 | 0 | 0 | 2 | 24 | 4 | 24 |
| GI | 136 | 1 | 52 | 8 | 97 | 20 | 122 |
| GU | 366 | 6 | 313 | 22 | 268 | 49 | 298 |
| LEUK | 86 | 1 | 52 | 9 | 110 | 15 | 91 |
| LUNG | 106 | 3 | 157 | 9 | 110 | 18 | 110 |
| LYMPH | 257 | 4 | 209 | 21 | 256 | 39 | 237 |
| MELAN | 174 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 99 | 0 | 0 | 4 | 49 | 7 | 43 |
| MULT | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
| OTHER | 40 | 0 | 0 | 3 | 37 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1947 | 29 | 1513 | 138 | 1681 | 290 | 1765 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 103 | 0 | 0 | 12 | 146 | 26 | 158 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 300 | 2 | 104 | 16 | 195 | 47 | 286 |
| LUNG | 193 | 3 | 157 | 21 | 256 | 42 | 256 |
| OTHER | 36 | 1 | 52 | 4 | 49 | 10 | 61 |
| PEOLC | 92 | 2 | 104 | 11 | 134 | 25 | 152 |
| PREV | 204 | 2 | 104 | 23 | 280 | 44 | 268 |
| SURV | 18 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 379 | 4 | 209 | 30 | 365 | 61 | 371 |
| Total | 1335 | 14 | 730 | 119 | 1449 | 260 | 1582 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 802 | 16 | 835 | 62 | 755 | 153 | 931 |
| CCD | 133 | 0 | 0 | 11 | 134 | 27 | 164 |
| ERLYTX | 58 | 0 | 0 | 2 | 24 | 5 | 30 |
| GI | 141 | 1 | 52 | 7 | 85 | 20 | 122 |
| GU | 382 | 5 | 261 | 25 | 304 | 55 | 335 |
| LEUK | 386 | 3 | 157 | 25 | 304 | 62 | 377 |
| LUNG | 300 | 6 | 313 | 30 | 365 | 60 | 365 |
| LYMPH | 257 | 4 | 209 | 21 | 256 | 39 | 237 |
| MELAN | 174 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 96 | 0 | 0 | 4 | 49 | 7 | 43 |
| MULT | 24 | 1 | 52 | 3 | 37 | 8 | 49 |
| OTHER | 258 | 3 | 157 | 20 | 244 | 43 | 262 |
| PEOLC | 96 | 2 | 104 | 10 | 122 | 25 | 152 |
| PREV | 206 | 2 | 104 | 23 | 280 | 44 | 268 |
| SURV | 18 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 381 | 4 | 209 | 30 | 365 | 61 | 371 |
| Total | 3712 | 47 | 2453 | 276 | 3360 | 615 | 3742 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 848 | 16 | 835 | 67 | 816 | 153 | 931 |
| ERLYTX | 85 | 0 | 0 | 3 | 37 | 8 | 49 |
| GI | 108 | 1 | 52 | 7 | 85 | 14 | 85 |
| GU | 254 | 6 | 313 | 22 | 268 | 45 | 274 |
| LEUK | 108 | 1 | 52 | 5 | 61 | 14 | 85 |
| LUNG | 135 | 2 | 104 | 16 | 195 | 33 | 201 |
| LYMPH | 323 | 5 | 261 | 22 | 268 | 47 | 286 |
| MMYEL | 140 | 1 | 52 | 6 | 73 | 10 | 61 |
| MULT | 22 | 0 | 0 | 7 | 85 | 12 | 73 |
| Total | 2023 | 32 | 1669 | 155 | 1888 | 336 | 2045 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1930 | 24 | 1252 | 158 | 1924 | 337 | 2051 |
| AFFIL | 120 | 3 | 157 | 16 | 195 | 29 | 177 |
| CCOP/NCORP | 1232 | 16 | 835 | 83 | 1011 | 184 | 1120 |
| Non-SWOG | 1692 | 19 | 991 | 126 | 1534 | 280 | 1705 |
| Total | 4974 | 62 | 3235 | 383 | 4664 | 830 | 5053 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | A031801 | GU, mRCC, Cabozantinib ± Radium-223 | 1 | E | 19-DEC-25 |
| LUNG | S1827 | SCLC, MRI Surveillance +/- PCI | 1 | N | 15-DEC-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 14 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 7 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 5 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 4 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 4 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 3 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 3 |
| LYMPH | S2114 | NHL, Rel/Ref, CD19 CAR-T +/- Consolidation | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |